LifeLens Technologies

What LifeLens Technologies does

LifeLens Technologies, Inc. is a privately held Delaware-incorporated biotechnology company founded in 2014 and headquartered in Warminster, Pennsylvania. It develops a physiological monitoring platform built around an ultra-wearable patch-based sensor that simultaneously captures multiple biosignals — ECG, EEG, EOG, EMG, ballistocardiograms, heart rate, heart rate variability, respiration rate, pulse oximetry, and skin temperature — together with contextual and environmental data such as blast detection, geolocation, posture, gait, and audio. The core regulated product, the LifeLens Wireless ECG Monitor, holds FDA 510(k) clearance for ambulatory ECG monitoring in adults 18 and older, with additional vital signs currently 510(k) pending.

The platform is positioned for two primary customer segments. The lead segment is the U.S. Department of Defense, where the technology has been tested in over 40 fielding events since 2021, with named deployments to Special Operations Forces and the U.S. Army 4th Infantry Division for casualty triage and large-scale combat operations experimentation. The secondary segment is healthcare and clinical providers, served through the FDA-cleared ECG monitor with expansion contingent on additional 510(k) clearances.

LifeLens operates a direct enterprise sales motion targeting government and healthcare buyers, with website-based demo and pricing inquiries and no publicly disclosed price list. Revenue mechanics combine hardware device sales (patches, sensors, communications modules, deployment kits) with a software platform layer that delivers real-time and retrospective visualization, analytics, and integration with DoD-standard tactical platforms (ATAK, WinTak, BATDOK). The company is currently capital-raising rather than cash-flow self-sufficient, having filed SEC Form D exempt offerings of approximately $35 million in July 2024 and $23.17 million in November 2025, with BayCrest Partners LLC engaged as placement agent.

Name

LifeLens Technologies

Legal name

LifeLens Technologies, Inc.

Website

https://lifelenstech.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

51–100 employees

Short description

LifeLens Technologies develops an FDA-cleared, patch-based wearable physiological monitoring platform that captures multi-signal biosensor data for the U.S. Department of Defense and healthcare providers. It combines hardware sensors with analytics and integrations into military tactical ecosystems.

Ownership category

akta.pro rank

Product category

Wearable Physiological Monitoring Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)

Keywords

• Wearable physiological monitoring
• Biomedical sensor devices
• Military health monitoring
• Ambulatory ECG monitoring
• Tactical health sensors

Headquarters

HQ city

Warminster

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Hardware Device Sales: Sale of wearable physiological monitoring sensor devices and associated hardware including sensors, communications modules, chargers, and deployment kits for individual and bulk deployment configurations.
2. Software Platform/Subscription: Continuous physiological monitoring platform providing real-time visualization, retrospective reporting, intelligence picture updates, and data analytics capabilities likely delivered as ongoing subscription or license.
3. Defense/government Contracts: Platform proven through U.S. military testing with deployment to special operators and 4th Infantry Division, suggesting government procurement and defense contract revenue streams.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

LifeLens Technologies develops and sells an ultra-wearable patch-based physiological monitoring platform that simultaneously captures multiple vital signs (ECG, EEG, EOG, EMG, ballistocardiograms, heart rate/HRV, SpO2, respiration, temperature) along with contextual and environmental data. The platform includes an FDA-cleared wireless ECG monitor and a real-time visualization and analytics software suite that serves both military/tactical and clinical healthcare customers. It is sold primarily as a hardware-plus-software integrated solution to enterprise and government buyers.

Product overview

LifeLens Technologies offers a unified platform architecture centered on the LifeLens Physiological Monitoring Platform, a comprehensive information acquisition, analysis, communication, and visualization solution. At its core is the FDA-cleared LifeLens Wireless ECG Monitor, a small, ultra-wearable, rechargeable, and reusable patch-based sensor device. The platform integrates multiple physiological sensors (ECG, EEG, EOG, EMG, ballistocardiograms, heart rate, SpO2, respiration, temperature), contextual and environmental sensors (blast detection, geolocation, audio capture, posture, gait), and communication capabilities (configurable mesh architecture, multiple connectivity options). The platform is designed for both military defense applications and healthcare solutions, providing real-time and retrospective data visualization. The technology has been tested in over 40 U.S. military fielding events since 2021.

Differentiator

Problem solved

Functional benefit

Products and services

• LifeLens Physiological Monitoring Platform A comprehensive information acquisition, analysis, communication, and visualization platform that simultaneously monitors physiological, contextual, and environmental data through wearable patch-based sensors. Designed for Department of Defense and healthcare enterprise buyers requiring real-time and retrospective monitoring of individuals and teams.
• LifeLens Wireless ECG Monitor An FDA-cleared, small-footprint, rechargeable, reusable patch-based wireless ECG monitor for ambulatory monitoring of patients 18 years or older who may be asymptomatic or experience transient symptoms such as palpitations, shortness of breath, dizziness, fatigue, chest pain, or anxiety. Not intended for use during defibrillation.

Quantifiable outcome

• Monitoring 400+ performance and recovery metrics for individuals and teams
• +3 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability5 records

Feature5 records

Partnerships

One partnership is on record.

• BayCrest Partners LLCcoreChannel Partner/ Reseller/ DistributorBayCrest Partners LLC has been engaged by LifeLens Technologies for securities sales activities. As placement agent, BayCrest assists with capital raising efforts including the $23.17 million exempt offering (2025) and $35 million offering (2024).

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Equivital: Equivital provides wearable physiological monitoring (EQ02 LifeMonitor) used by military, first responders, and industrial safety programs. Direct peer offering multi-signal chest-worn wearables with comparable defense and industrial use cases.
• Empatica: Empatica offers FDA-cleared wearable health monitors (EpiMonitor for epilepsy, Embrace) with multi-signal physiological sensing. Direct peer in regulated clinical-grade wearables with a comparable patch/wrist form factor strategy.
• BioIntellisense: BioIntellisense provides the BioSticker and BioButton continuous clinical-grade monitoring devices. Direct peer in FDA-cleared wearable vital signs monitoring for remote patient monitoring applications.

Broad incumbents

• Garmin Health: Garmin produces tactical wearables (Instinct Tactical, tactix series) and a broader health/wellness wearable portfolio. Broad incumbent that competes for both defense and consumer health wearable mindshare but is not patch-based or multi-signal in the same way.
• Polar Electro: Polar offers wearable HR, HRV, and physiological monitoring adopted by military and first responder programs. Broad incumbent in wearable physiological monitoring with comparable sensing but consumer/sport positioning.
• Philips Remote Patient Monitoring: Philips provides enterprise remote patient monitoring platforms used by hospitals and health systems. Broad incumbent whose installed base and clinical relationships would compete with LifeLens' healthcare expansion once additional 510(k) clearances are obtained.
• Masimo: Masimo manufactures SET pulse oximetry and patient monitoring technologies with hospital-grade credibility. Broad incumbent that competes in the vital signs monitoring category LifeLens targets with its 510(k) pending suite.
• Medtronic (Zephyr/BioHarness): Medtronic acquired Zephyr, a pioneer in wearable physiological monitoring historically used by military and first responders. Broad incumbent with established defense programs and clinical distribution that competes in the same category.
• Apple (Apple Watch Health): Apple Watch includes FDA-cleared ECG and broader health features that compete for consumer and entry-level clinical attention. Broad incumbent whose scale and consumer reach may pressure pricing and adoption in adjacent wearable health segments.

Emerging players

• Whoop: Whoop offers subscription-based wearable physiological monitoring focused on recovery, strain, and HRV. Emerging player that overlaps in continuous physiological monitoring with a consumer/sports positioning rather than military/tactical.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/lifelens-technologies-llc

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LifeLens Technologies